Skip to main content
ImmuneCited

Echinacea 관련 Upper Respiratory Tract Infections

B

Cochrane-reviewed meta-analyses suggest echinacea may modestly reduce cold duration and severity when started at symptom onset. Daily prophylactic use may reduce cold risk. Individual trial effects are small but consistently positive across multiple preparations.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'ingredient\u003Dechinacea\u0026condition\u003Dupper\u002Drespiratory\u002Dinfections'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

결론

Cochrane-reviewed meta-analyses suggest echinacea may modestly reduce cold duration and severity when started at symptom onset. Daily prophylactic use may reduce cold risk. Individual trial effects are small but consistently positive across multiple preparations.

Key Study Findings

Meta-Analysis n=3169
Efficacy and safety of Echinacea purpurea in treating upper respiratory infections and complications of otitis …
Dose: None vs: Placebo Outcome: URTI treatment duration, incidence, antibiotic use 효과: SMD=-0.19 (duration); RR=0.81 (incidence) <0.01

대상 집단: Children with URTI and otitis media (9 RCTs)

Review
Plant-Based Support of Respiratory Health during Viral Outbreaks.
Dose: None vs: None Outcome: None 효과: None None

대상 집단: None

Meta-Analysis
Echinacea for the prevention and treatment of upper respiratory tract infections: A systematic review and …
Dose: None vs: Placebo Outcome: Upper respiratory tract infection 효과: None None

대상 집단: None

Meta-Analysis n=3135 13.0 weeks
Efficacy of vitamin C for the prevention and treatment of upper respiratory tract infection. A …
Dose: None vs: Placebo Outcome: Upper respiratory tract infection 효과: odds ratio = 0.75 p=0.07

대상 집단: children

In Vitro
Prevention and Treatment of Influenza, Influenza-Like Illness, and Common Cold by Herbal, Complementary, and Natural …
Dose: None vs: Placebo Outcome: Influenza and common cold prevention/treatment 효과: None None

대상 집단: General population with respiratory infections

Randomized Controlled Trial n=177 Double-blind
Antitussive effect of a fixed combination of Justicia adhatoda, Echinacea purpurea and Eleutherococcus senticosus extracts …
Dose: 30 ml/day vs: placebo Outcome: cough relief, which was assessed as the change … 효과: None None

대상 집단: men

Key Statistics

20

연구

4000

참여자

Positive

B

등급

Referenced Papers

Journal of agricultural … 2022 9 인용
American family physician 2012
International journal of … 2007 41 인용
Southern medical journal 2005 35 인용
Clinical evidence 2003
Clinical evidence 2003
American family physician 2002

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

일반적으로 사용되는 용량

general:
300-500 mg standardized extract 3x/day
acuteuse:
At first sign of symptoms for 7-10 days

상한량: No established UL; generally used for 10 days or less

연구에서 사용된 용량

용량 기간 효과 N
None -- Positive 3169
None -- Mixed --
None -- Positive --
None 13.0 weeks Mixed 3135
None -- Positive --
30 ml/day -- Positive 177
None -- Neutral --
None -- Mixed --

권장 복용 시간: At first sign of symptoms; multiple doses throughout the day

Safety & Side Effects

보고된 부작용

  • Gastrointestinal upset (nausea, stomach pain)
  • Allergic reactions (especially in those allergic to daisies, ragweed)
  • Headache
  • Dizziness

알려진 상호작용

  • Immunosuppressant medications (may counteract immunosuppression)
  • CYP3A4 substrates (may alter metabolism of various drugs)
  • Caffeine (may slow caffeine metabolism)
  • Anabolic steroids and methotrexate (increased hepatotoxicity risk)

일일 최대 섭취 허용량: No established UL; generally used for 10 days or less

건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.

Frequently Asked Questions

Does Echinacea help with Upper Respiratory Tract Infections?
Based on 20 studies with 4,000 participants, there is moderate evidence from clinical studies that Echinacea may support Upper Respiratory Tract Infections management. Our evidence grade is B (Good Evidence).
How much Echinacea should I take for Upper Respiratory Tract Infections?
Studies have used various dosages. A commonly studied range is 300-500 mg standardized extract 3x/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Echinacea?
Reported side effects may include Gastrointestinal upset (nausea, stomach pain), Allergic reactions (especially in those allergic to daisies, ragweed), Headache, Dizziness. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Echinacea and Upper Respiratory Tract Infections?
We rate the evidence as Grade B (Good Evidence). This rating is based on 20 peer-reviewed studies with 4,000 total participants. The overall direction of effect is positive.

Related Evidence

관련 다른 성분: Upper Respiratory Tract Infections

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.